Biomarkers of dementia in obstructive sleep apnea
dc.contributor.author | Baril, Andrée-Ann | |
dc.contributor.author | Carrier, Julie | |
dc.contributor.author | Lafrenière, Alexandre | |
dc.contributor.author | Warby, Simon | |
dc.contributor.author | Poirier, Judes | |
dc.contributor.author | Osorio, Ricardo S. | |
dc.contributor.author | Ayas, Najib | |
dc.contributor.author | Dubé, Marie-Pierre | |
dc.contributor.author | Petit, Dominique | |
dc.contributor.author | Gosselin, Nadia | |
dc.contributor.author | Canadian Sleep and Circadian Network | |
dc.date.accessioned | 2019-04-09T17:42:05Z | |
dc.date.available | MONTHS_WITHHELD:12 | fr |
dc.date.available | 2019-04-09T17:42:05Z | |
dc.date.issued | 2018-08-13 | |
dc.identifier.uri | http://hdl.handle.net/1866/21538 | |
dc.publisher | Elsevier | fr |
dc.subject | Sleep-disordered breathing | fr |
dc.subject | Alzheimer’s disease | fr |
dc.subject | Vascular dementia | fr |
dc.subject | Mild cognitive impairment | fr |
dc.subject | Cerebrospinal fluid | fr |
dc.subject | Proteomics | fr |
dc.subject | Metabolomics | fr |
dc.subject | Genomics | fr |
dc.subject | Inflammation | fr |
dc.subject | Oxidative stress | fr |
dc.title | Biomarkers of dementia in obstructive sleep apnea | fr |
dc.type | Article | fr |
dc.contributor.affiliation | Université de Montréal. Faculté des arts et des sciences. Département de psychologie | fr |
dc.identifier.doi | 10.1016/j.smrv.2018.08.001 | |
dcterms.abstract | Epidemiologic and mechanistic evidence is increasingly supporting the notion that obstructive sleep apnea is a risk factor for dementia. Hence, the identification of patients at risk of cognitive decline due to obstructive sleep apnea may significantly improve preventive strategies and treatment decisionmaking. Cerebrospinal fluid and blood biomarkers obtained through genomic, proteomic and metabolomic approaches are improving the ability to predict incident dementia. Therefore, fluid biomarkers have the potential to predict vulnerability to neurodegeneration in individuals with obstructive sleep apnea, as well as deepen our understanding of pathophysiological processes linking obstructive sleep apnea and dementia. Many fluid biomarkers linked to Alzheimer’s disease and vascular dementia show abnormal levels in individuals with obstructive sleep apnea, suggesting that these conditions share common underlying mechanisms, including amyloid and tau protein neuropathology, inflammation, oxidative stress, and metabolic disturbances. Markers of these processes include amyloid-β, tau proteins, inflammatory cytokines, acute-phase proteins, antioxydants and oxidized products, homocysteine and clusterin (apolipoprotein J). Thus, these biomarkers may have the ability to identify adults with obstructive sleep apnea at high risk of dementia and provide an opportunity for therapeutic intervention. Large cohort studies are necessary to establish a specific fluid biomarker panel linking obstructive sleep apnea to dementia risk. | fr |
dcterms.isPartOf | urn:ISSN:1087-0792 | fr |
dcterms.isPartOf | urn:ISSN:1532-2955 | fr |
dcterms.language | eng | fr |
UdeM.ReferenceFournieParDeposant | PMID: 30241998 DOI: 10.1016/j.smrv.2018.08.001 | fr |
UdeM.VersionRioxx | Version acceptée / Accepted Manuscript | fr |
oaire.citationTitle | Sleep medicine reviews | |
oaire.citationVolume | 42 | |
oaire.citationStartPage | 139 | |
oaire.citationEndPage | 148 |
Fichier·s constituant ce document
Ce document figure dans la ou les collections suivantes
Ce document diffusé sur Papyrus est la propriété exclusive des titulaires des droits d'auteur et est protégé par la Loi sur le droit d'auteur (L.R.C. (1985), ch. C-42). Il peut être utilisé dans le cadre d'une utilisation équitable et non commerciale, à des fins d'étude privée ou de recherche, de critique ou de compte-rendu comme le prévoit la Loi. Pour toute autre utilisation, une autorisation écrite des titulaires des droits d'auteur sera nécessaire.